Jci_page_head_homepage_01 Jci_page_head_homepage_02
Masaki Ieda, Keiichi Fukuda, Yasuyo Hisaka, Kensuke Kimura, Haruko Kawaguchi, Jun Fujita, Kouji Shimoda, Eiko Takeshita, Hideyuki Okano, Yukiko Kurihara, Hiroki Kurihara, Junji Ishida, Akiyoshi Fukamizu, Howard J. Federoff, Satoshi Ogawa
Published in Volume 113, Issue 6
J Clin Invest. 2004; 113(6):876–884 doi:10.1172/JCI19480
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4

Disruption of ET-1, but not of angiotensinogen, reduces NGF expression, sympathetic nerve density, and norepinephrine concentration in murine hearts. (A) NGF expression in Edn1+/+, Edn1–/–, Atg+/+, and Atg–/– hearts at E18.5 was determined by quantitative RT-PCR (n = 10). (B) Neurotrophin-3 (NT-3) expression in the heart was measured by quantitative RT-PCR. The same reverse transcription products used in A were analyzed. (n = 10.) (C) Immunostaining for GAP43, PGP9.5, and TH in the heart. Nerves were restricted to the epicardium in both genotypes, and levels of GAP43, PGP9.5, and TH were lower in Edn1–/– mice, but not in Atg–/– mice, compared with WT littermates. (D–F) The immunopositive nerve areas for GAP43, PGP9.5, and TH were determined using NIH Image (n = 8). (G) Cardiac norepinephrine (NE) concentrations were measured by HPLC (n = 10). *P < 0.0001; **P < 0.005; #P < 0.01. NS, not significant. Scale bar: 100 μm.